|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/395 | (2006.01) |
| A61K 39/395 | (2013.01) | ||
| A61K 9/14 | (2006.01) | ||
| C07K 16/2818 | (2013.01) | ||
| A61K 39/39 | (2006.01) | ||
| C07K2317/14 | (2013.01) | ||
| A61K 39/00 | (2006.01) | ||
| C07K2317/24 | (2013.01) | ||
| C07K2317/52 | (2013.01) | ||
| C07K2317/53 | (2013.01) | ||
| A61K 39/0011 | (2013.01) | ||
| A61K 39/39 | (2013.01) | ||
| A61K2039/55555 | (2013.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 37/04 | (2018.01) | ||
| A61P 43/00 | (2018.01) |
| (11) | Number of the document | 3970748 |
| (13) | Kind of document | T |
| (96) | European patent application number | 21190343.0 |
| Date of filing the European patent application | 2015-12-24 | |
| (97) | Date of publication of the European application | 2022-03-23 |
| (45) | Date of publication and mention of the grant of the patent | 2024-07-24 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 201462096725 P | 2014-12-24 | US |
| (72) |
MCCREEDY, Bruce , US
|
| (73) |
NexImmune, Inc. ,
9119 Gaither Road, Gaithersburg, MD 20877,
US
|
| (54) | NANOPARTICLE COMPOSITIONS AND METHODS FOR IMMUNOTHERAPY |
| NANOPARTICLE COMPOSITIONS AND METHODS FOR IMMUNOTHERAPY |